IHH Healthcare Berhad Valuation

Is IHH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IHH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IHH (MYR7.03) is trading below our estimate of fair value (MYR12.05)

Significantly Below Fair Value: IHH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IHH?

Key metric: As IHH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IHH. This is calculated by dividing IHH's market cap by their current earnings.
What is IHH's PE Ratio?
PE Ratio23.4x
EarningsRM 2.65b
Market CapRM 61.95b

Price to Earnings Ratio vs Peers

How does IHH's PE Ratio compare to its peers?

The above table shows the PE ratio for IHH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average43.4x
KPJ KPJ Healthcare Berhad
35.8x11.5%RM 10.7b
FOCUSP Focus Point Holdings Berhad
10.7x11.7%RM 369.6m
CENGILD Cengild Medical Berhad
20xn/aRM 229.1m
543220 Max Healthcare Institute
107.1x30.8%₹1.1t
IHH IHH Healthcare Berhad
23.4x0.4%RM 62.0b

Price-To-Earnings vs Peers: IHH is good value based on its Price-To-Earnings Ratio (23.4x) compared to the peer average (43.4x).


Price to Earnings Ratio vs Industry

How does IHH's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
IHH 23.4xIndustry Avg. 20.9xNo. of Companies55PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IHH is expensive based on its Price-To-Earnings Ratio (23.4x) compared to the Asian Healthcare industry average (20.9x).


Price to Earnings Ratio vs Fair Ratio

What is IHH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IHH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.4x
Fair PE Ratio27.2x

Price-To-Earnings vs Fair Ratio: IHH is good value based on its Price-To-Earnings Ratio (23.4x) compared to the estimated Fair Price-To-Earnings Ratio (27.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IHH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 7.03
RM 8.01
+14.0%
7.3%RM 9.10RM 6.90n/a21
Dec ’25RM 7.26
RM 7.97
+9.8%
6.9%RM 9.10RM 7.10n/a21
Nov ’25RM 7.28
RM 7.68
+5.5%
5.9%RM 8.80RM 6.88n/a21
Oct ’25RM 7.24
RM 7.56
+4.4%
5.6%RM 8.80RM 6.88n/a21
Sep ’25RM 6.27
RM 7.47
+19.1%
5.6%RM 8.00RM 6.40n/a21
Aug ’25RM 6.32
RM 7.30
+15.5%
6.0%RM 8.00RM 6.40n/a21
Jul ’25RM 6.30
RM 7.26
+15.2%
6.2%RM 8.00RM 6.40n/a21
Jun ’25RM 6.19
RM 7.22
+16.7%
6.0%RM 7.90RM 6.40n/a20
May ’25RM 6.33
RM 7.13
+12.6%
6.4%RM 7.88RM 6.40n/a20
Apr ’25RM 6.08
RM 7.13
+17.3%
6.4%RM 7.88RM 6.40n/a20
Mar ’25RM 6.14
RM 7.08
+15.3%
6.4%RM 7.86RM 6.17n/a19
Feb ’25RM 6.10
RM 7.03
+15.2%
6.3%RM 7.70RM 6.30n/a18
Jan ’25RM 6.03
RM 7.00
+16.1%
6.3%RM 7.70RM 6.30n/a17
Dec ’24RM 5.84
RM 7.00
+19.9%
6.1%RM 7.70RM 6.30RM 7.2618
Nov ’24RM 5.99
RM 7.00
+16.9%
6.2%RM 7.70RM 6.22RM 7.2818
Oct ’24RM 5.85
RM 7.02
+20.0%
6.0%RM 7.70RM 6.22RM 7.2419
Sep ’24RM 5.88
RM 7.04
+19.7%
5.9%RM 7.70RM 6.22RM 6.2720
Aug ’24RM 5.94
RM 7.08
+19.2%
6.0%RM 7.70RM 6.28RM 6.3221
Jul ’24RM 5.89
RM 7.06
+19.8%
6.1%RM 7.70RM 6.28RM 6.3022
Jun ’24RM 5.74
RM 7.06
+23.1%
5.5%RM 7.63RM 6.30RM 6.1922
May ’24RM 5.73
RM 7.09
+23.8%
6.0%RM 7.80RM 6.30RM 6.3321
Apr ’24RM 5.75
RM 7.11
+23.6%
5.9%RM 7.80RM 6.30RM 6.0821
Mar ’24RM 5.71
RM 7.15
+25.2%
6.5%RM 7.90RM 6.30RM 6.1420
Feb ’24RM 5.92
RM 7.21
+21.8%
6.0%RM 7.90RM 6.38RM 6.1020
Jan ’24RM 6.22
RM 7.23
+16.3%
6.0%RM 7.90RM 6.38RM 6.0321
Dec ’23RM 5.79
RM 7.25
+25.2%
5.8%RM 7.90RM 6.38RM 5.8421

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IHH Healthcare Berhad is covered by 39 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chee ChowAffin Hwang Investment Bank
Lik Hsin AwAffin Hwang Investment Bank
Ken-Wern LimAffin Hwang Investment Bank